RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000071.xml
PDF herunterladen
Semin Neurol 2011; 31(3): 254-265
DOI: 10.1055/s-0031-1287653
© Thieme Medical PublishersDOI: 10.1055/s-0031-1287653
Atypical Nervous System Manifestations of HIV
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
30. September 2011 (online)
ABSTRACT
Despite the widespread success of combination antiretroviral therapy (cART) in reducing morbidity and mortality in human immunodeficiency virus 1 (HIV-1) infection, HIV-associated neurologic disease remains prevalent. Although the virus is unable to infect neurons or muscle fibers directly, it can still injure these structures by a variety of mechanisms, many of which are yet to be elucidated. Additionally, antiretroviral medications used to treat HIV infection can cause damage to the nervous system both by direct toxicity and via modulation of host-virus interactions. Some neurologic complications of HIV infection are rarely seen and are poorly understood; nevertheless, they are important to recognize. In this review article, the authors focus on the uncommon neurologic manifestations of HIV infection, including mononeuropathies, inflammatory demyelinating polyneuropathies, motor neuron disease, polymyositis, diffuse infiltrative lymphocytosis syndrome, mononeuritis multiplex, HIV-associated neuromuscular weakness syndrome, immune reconstitution inflammatory syndrome, and central nervous system HIV-escape meningoencephalomyelitis and myelitis.
KEYWORDS
Human immunodeficiency virus - HIV - peripheral neuropathy - immune reconstitution inflammatory syndrome - myopathy
REFERENCES
- 1 United Nations. UN AIDS Report on the Global AIDS Epidemic .Geneva: United Nations; 2010
- 2 McArthur J C, Brew B J, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005; 4 (9) 543-555
- 3 Morgello S, Estanislao L, Simpson D Manhattan HIV Brain Bank et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol. 2004; 61 (4) 546-551
- 4 Power C, Boissé L, Rourke S, Gill M J. NeuroAIDS: an evolving epidemic. Can J Neurol Sci. 2009; 36 (3) 285-295
- 5 An S F, Groves M, Gray F, Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol. 1999; 58 (11) 1156-1162
- 6 Davis L E, Hjelle B L, Miller V E et al.. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992; 42 (9) 1736-1739
- 7 Powderly W G. Current approaches to treatment for HIV-1 infection. J Neurovirol. 2000; 6 (Suppl 1) S8-S13
- 8 Crowe S, Zhu T, Muller W A. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol. 2003; 74 (5) 635-641
- 9 Gartner S. HIV infection and dementia. Science. 2000; 287 (5453) 602-604
- 10 Maslin C L, Kedzierska K, Webster N L, Muller W A, Crowe S M. Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection. Curr HIV Res. 2005; 3 (4) 303-317
- 11 McArthur J C, Steiner J, Sacktor N, Nath A. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol. 2010; 67 (6) 699-714
- 12 Massari F E, Poli G, Schnittman S M, Psallidopoulos M C, Davey V, Fauci A S. In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. J Immunol. 1990; 144 (12) 4628-4632
- 13 Churchill M J, Gorry P R, Cowley D et al.. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol. 2006; 12 (2) 146-152
- 14 Gorry P R, Ong C, Thorpe J et al.. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res. 2003; 1 (4) 463-473
- 15 Li W, Li G, Steiner J, Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox Res. 2009; 16 (3) 205-220
- 16 Thompson K A, Churchill M J, Gorry P R et al.. Astrocyte specific viral strains in HIV dementia. Ann Neurol. 2004; 56 (6) 873-877
- 17 Churchill M J, Wesselingh S L, Cowley D et al.. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol. 2009; 66 (2) 253-258
- 18 Dunfee R, Thomas E R, Gorry P R, Wang J, Ancuta P, Gabuzda D. Mechanisms of HIV-1 neurotropism. Curr HIV Res. 2006; 4 (3) 267-278
- 19 Everall I P, Luthert P J, Lantos P L. Neuronal loss in the frontal cortex in HIV infection. Lancet. 1991; 337 (8750) 1119-1121
- 20 Wiley C A, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol. 1994; 36 (4) 673-676
- 21 González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005; 5 (1) 69-81
- 22 Ancuta P, Kamat A, Kunstman K J et al.. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE. 2008; 3 (6) e2516
- 23 McArthur J C, Haughey N, Gartner S et al.. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003; 9 (2) 205-221
- 24 Ho D D, Rota T R, Schooley R T et al.. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985; 313 (24) 1493-1497
- 25 Keswani S C, Polley M, Pardo C A, Griffin J W, McArthur J C, Hoke A. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol. 2003; 54 (3) 287-296
- 26 Pardo C A, McArthur J C, Griffin J W. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst. 2001; 6 (1) 21-27
- 27 Heckmann J M, Pillay K, Hearn A P, Kenyon C. Polymyositis in African HIV-infected subjects. Neuromuscul Disord. 2010; 20 (11) 735-739
- 28 Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol. 1991; 29 (5) 474-481
- 29 Robinson-Papp J, Simpson D M. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 2009; 40 (6) 1043-1053
- 30 Sheikh S I, Nijhawan A, Basgoz N, Venna N. Reversible Cogan's syndrome in a patient with human immunodeficiency virus (HIV) infection. J Clin Neurosci. 2009; 16 (1) 154-156
- 31 Lange D J. AAEM minimonograph #41: neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 1994; 17 (1) 16-30
- 32 Serrano P, Hernández N, Arroyo J A, de Llobet J M, Domingo P. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis. 2007; 44 (6) e57-e61
- 33 Verma A, Berger J R. ALS syndrome in patients with HIV-1 infection. J Neurol Sci. 2006; 240 (1-2) 59-64
- 34 Power C, Johnson R T. Emerging Neurological Infections. Boca Raton, FL: Taylor and Francis Group; 2005
- 35 Murdoch D M, Venter W D, Feldman C, Van Rie A. HIV immune reconstitution syndrome in sub-Saharan Africa. AIDS. 2008; 22 (13) 1689-1690
- 36 Shelburne S A, Visnegarwala F, Darcourt J et al.. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005; 19 (4) 399-406
- 37 Bélec L, Gherardi R, Georges A J et al.. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol. 1989; 236 (7) 411-414
- 38 Komolafe M A, Fatusi O A, Alatise O I et al.. The role of human immunodeficiency virus infection in infranuclear facial paralysis. J Natl Med Assoc. 2009; 101 (4) 361-366
- 39 Chand V, Sweeney C, Agger W A. Mental neuropathy in patients with AIDS-associated malignant lymphoma. Clin Infect Dis. 1997; 24 (3) 521-522
- 40 Brannagan III T H, Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci. 2003; 208 (1-2) 39-42
- 41 Souayah N, Mian N F, Gu Y, Ilyas A A. Elevated anti-sulfatide antibodies in Guillain-Barré syndrome in T cell depleted at end-stage AIDS. J Neuroimmunol. 2007; 188 (1-2) 143-145
- 42 Cornblath D R, McArthur J C, Kennedy P G, Witte A S, Griffin J W. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987; 21 (1) 32-40
- 43 Schleicher G K, Black A, Mochan A, Richards G A. Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barré syndrome. Crit Care Med. 2003; 31 (6) 1848-1850
- 44 Vendrell J, Heredia C, Pujol M, Vidal J, Blesa R, Graus F. Guillain-Barré syndrome associated with seroconversion for anti-HTLV-III. Neurology. 1987; 37 (3) 544
- 45 Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol. 1978; 3 (6) 565-566
- 46 Bani-Sadr F, Neuville S, Crassard I, Guihot A, Molina J M. Acute Guillain-Barré syndrome during the chronic phase of HIV infection and dramatic improvement under highly active antiretroviral therapy. AIDS. 2002; 16 (11) 1562
- 47 Thornton C A, Latif A S, Emmanuel J C. Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology. 1991; 41 (6) 812-815
- 48 Chen-Plotkin A S, Christopoulos K A, Venna N. Demyelinating polyneuropathy and herpes simplex lumbosacral radiculitis in a patient with chronic HIV infection. AIDS. 2007; 21 (12) 1663-1664
- 49 Benatar M G, Eastman R W. Human immunodeficiency virus-associated pure motor lumbosacral polyradiculopathy. Arch Neurol. 2000; 57 (7) 1034-1039
- 50 Verma R K, Ziegler D K, Kepes J J. HIV-related neuromuscular syndrome simulating motor neuron disease. Neurology. 1990; 40 (3 Pt 1) 544-546
- 51 Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology. 2001; 57 (6) 995-1001
- 52 Galassi G, Gentilini M, Ferrari S et al.. Motor neuron disease and HIV-1 infection in a 30-year-old HIV-positive heroin abuser: a causal relationship?. Clin Neuropathol. 1998; 17 (3) 131-135
- 53 Hoffman P M, Festoff B W, Giron Jr L T, Hollenbeck L C, Garruto R M, Ruscetti F W. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N Engl J Med. 1985; 313 (5) 324-325
- 54 MacGowan D J, Scelsa S N, Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2001; 57 (6) 1094-1097
- 55 Jubelt B. Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas. Curr Opin Neurol Neurosurg. 1992; 5 (5) 655-658
- 56 MacGowan D J, Scelsa S N, Imperato T E, Liu K N, Baron P, Polsky B. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology. 2007; 68 (22) 1944-1946
- 57 Westarp M E, Ferrante P, Perron H, Bartmann P, Kornhuber H H. Sporadic ALS/MND: a global neurodegeneration with retroviral involvement?. J Neurol Sci. 1995; 129 (Suppl) 145-147
- 58 Ferrante P, Westarp M E, Mancuso R et al.. HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis. J Neurol Sci. 1995; 129 (Suppl) 140-144
- 59 Andrews W D, Al-Chalabi A, Garson J A. Lack of evidence for HTLV tax-rex DNA in motor neurone disease. J Neurol Sci. 1997; 153 (1) 86-90
- 60 Cone L A, Nazemi R, Cone M O. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2002; 59 (3) 474 author reply 474-475
- 61 Sola P, Bedin R, Casoni F, Barozzi P, Mandrioli J, Merelli E. New insights into the viral theory of amyotrophic lateral sclerosis: study on the possible role of Kaposi's sarcoma-associated virus/human herpesvirus 8. Eur Neurol. 2002; 47 (2) 108-112
- 62 Simpson D M, Morgello S, Citak K, Corbo M, Latov N. Motor neuron disease associated with HIV-1 and Anti-Asialo GM1 antibody. Muscle Nerve. 1994; 17 1091
- 63 Brooks B R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994; 124 (Suppl) 96-107
- 64 Berger J R, Espinosa P S, Kissel J. Brachial amyotrophic diplegia in a patient with human immunodeficiency virus infection: widening the spectrum of motor neuron diseases occurring with the human immunodeficiency virus. Arch Neurol. 2005; 62 (5) 817-823
- 65 Henning F, Hewlett R H. Brachial amyotrophic diplegia (segmental proximal spinal muscular atrophy) associated with HIV infection. J Neurol Neurosurg Psychiatry. 2008; 79 (12) 1392-1394
- 66 Verma A, Berger J R. Primary lateral sclerosis with HIV-1 infection. Neurology. 2008; 70 (7) 575-577
- 67 Scelsa S N, MacGowan D J, Mitsumoto H et al.. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS. Neurology. 2005; 64 (7) 1298-1300
- 68 Simpson D M, Citak K A, Godfrey E, Godbold J, Wolfe D E. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?. Neurology. 1993; 43 (5) 971-976
- 69 Dalakas M C, Rakocevic G, Shatunov A, Goldfarb L, Raju R, Salajegheh M. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann Neurol. 2007; 61 (5) 466-475
- 70 Simpson D M, Bender A N. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol. 1988; 24 (1) 79-84
- 71 Johnson R W, Williams F M, Kazi S, Dimachkie M M, Reveille J D. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum. 2003; 49 (2) 172-178
- 72 Snider W D, Simpson D M, Nielsen S, Gold J W, Metroka C E, Posner J B. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983; 14 (4) 403-418
- 73 Sellier P, Monsuez J J, Evans J et al.. Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy. Am J Med. 2000; 109 (6) 510-512
- 74 Williams F M, Cohen P R, Jumshyd J, Reveille J D. Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheum. 1998; 41 (5) 863-868
- 75 Basu D, Williams F M, Ahn C W, Reveille J D. Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum. 2006; 55 (3) 466-472
- 76 Itescu S, Brancato L J, Buxbaum J et al.. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med. 1990; 112 (1) 3-10
- 77 Authier F J, Gheradi R K. Peripheral neuropathies in HIV-infected patients in the era of HAART. Brain Pathol. 2003; 13 (2) 223-228
- 78 Gherardi R K, Chrétien F, Delfau-Larue M H et al.. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology. 1998; 50 (4) 1041-1044
- 79 Moulignier A, Authier F J, Baudrimont M et al.. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol. 1997; 41 (4) 438-445
- 80 Kolson D L, Gonzalez-Scarano F. HIV-associated neuropathies: role of HIV-1, CMV, and other viruses. J Peripher Nerv Syst. 2001; 6 (1) 2-7
- 81 Morgello S, Simpson D M. Multifocal cytomegalovirus demyelinative polyneuropathy associated with AIDS. Muscle Nerve. 1994; 17 (2) 176-182
- 82 Simpson D M, Olney R K. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin. 1992; 10 (3) 685-711
- 83 Wulff E A, Wang A K, Simpson D M. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000; 59 (6) 1251-1260
- 84 So Y T, Olney R K. The natural history of mononeuritis multiplex and simplex in HIV-infection. Neurology. 1991; 41 (Suppl 1) 375
- 85 HIV Neuromuscular Syndrome Study Group . HIV-associated neuromuscular weakness syndrome. AIDS. 2004; 18 (10) 1403-1412
- 86 French M A, Mallal S A, Dawkins R L. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS. 1992; 6 (11) 1293-1297
- 87 Shelburne S A, Montes M, Hamill R J. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother. 2006; 57 (2) 167-170
- 88 Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F. French Cryptococcosis Study Group . Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS. 2005; 19 (10) 1043-1049
- 89 Woods II M L, MacGinley R, Eisen D P, Allworth A M. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS. 1998; 12 (12) 1491-1494
- 90 Murdoch D M, Venter W D, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008; 22 (5) 601-610
- 91 Grant P M, Komarow L, Andersen J et al.. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS ONE. 2010; 5 (7) e11416
- 92 Shelburne III S A, Darcourt J, White Jr A C et al.. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005; 40 (7) 1049-1052
- 93 French M A, Price P, Stone S F. Immune restoration disease after antiretroviral therapy. AIDS. 2004; 18 (12) 1615-1627
- 94 Johnson T, Nath A. Neurological complications of immune reconstitution in HIV-infected populations. Ann N Y Acad Sci. 2010; 1184 106-120
- 95 Marais S, Wilkinson R J, Pepper D J, Meintjes G. Management of patients with the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep. 2009; 6 (3) 162-171
- 96 Zolopa A, Andersen J, Powderly W et al.. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE. 2009; 4 (5) e5575
- 97 McCombe J A, Auer R N, Maingat F G, Houston S, Gill M J, Power C. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology. 2009; 72 (9) 835-841
- 98 Autran B, Carcelain G, Li T S et al.. Positive effects of combined antiretroviral therapy on CD4 + T cell homeostasis and function in advanced HIV disease. Science. 1997; 277 (5322) 112-116
- 99 Miller R F, Isaacson P G, Hall-Craggs M et al.. Cerebral CD8 + lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol. 2004; 108 (1) 17-23
- 100 Chávez-Galán L, Arenas-Del Angel M C, Zenteno E, Chávez R, Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol. 2009; 6 (1) 15-25
- 101 Haddow L J, Colebunders R, Meintjes G International Network for the Study of HIV-associated IRIS (INSHI) et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010; 10 (11) 791-802
- 102 Asselman V, Thienemann F, Pepper D J et al.. Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS. 2010; 24 (18) 2871-2876
- 103 Cattelan A M, Trevenzoli M, Sasset L, Lanzafame M, Marchioro U, Meneghetti F. Multiple cerebral cryptococcomas associated with immune reconstitution in HIV-1 infection. AIDS. 2004; 18 (2) 349-351
- 104 Dautremer J, Pacanowski J, Girard P M, Lalande V, Sivignon F, Meynard J L. A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis. AIDS. 2007; 21 (3) 381-382
- 105 Meintjes G, Lawn S D, Scano F International Network for the Study of HIV-associated IRIS et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008; 8 (8) 516-523
- 106 Tan K, Roda R, Ostrow L, McArthur J, Nath A. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology. 2009; 72 (17) 1458-1464
- 107 Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis. 2006; 19 (1) 20-25
- 108 Venkataramana A, Pardo C A, McArthur J C et al.. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology. 2006; 67 (3) 383-388
- 109 Berger J R. Steroids for PML-IRIS: a double-edged sword?. Neurology. 2009; 72 (17) 1454-1455
- 110 Sax P E, Sloan C E, Schackman B R Cepac US And Actg A5164 Investigators et al. Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. HIV Clin Trials. 2010; 11 (5) 248-259
- 111 Canestri A, Lescure F X, Jaureguiberry S et al.. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis. 2010; 50 (5) 773-778
- 112 Letendre S, Marquie-Beck J, Capparelli E CHARTER Group et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008; 65 (1) 65-70
- 113 Letendre S L, Ellis R J, Ances B M, McCutchan J A. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2010; 18 (2) 45-55
- 114 Boissé L, Gill M J, Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin. 2008; 26 (3) 799-819
- 115 Connor M D, Lammie G A, Bell J E, Warlow C P, Simmonds P, Brettle R D. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke. 2000; 31 (9) 2117-2126
- 116 Brilla R, Nabavi D G, Schulte-Altedorneburg G et al.. Cerebral vasculopathy in HIV infection revealed by transcranial Doppler: A pilot study. Stroke. 1999; 30 (4) 811-813
- 117 Dal Pan G J, Glass J D, McArthur J C. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study. Neurology. 1994; 44 (11) 2159-2164
- 118 Grant I, Martin A. Neuropathology of HIV Infection. Vol. 494. New York: Oxford University Press; 1994
- 119 Lang W, Miklossy J, Deruaz J P et al.. Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol. 1989; 77 (4) 379-390
- 120 Rosenblum M L, Levy R M, Bredesen D E, So Y T, Wara W, Ziegler J L. Primary central nervous system lymphomas in patients with AIDS. Ann Neurol. 1988; 23 (Suppl) S13-S16
- 121 Welch K, Finkbeiner W, Alpers C E et al.. Autopsy findings in the acquired immune deficiency syndrome. JAMA. 1984; 252 (9) 1152-1159
- 122 Anderson A M, Fountain J A, Green S B, Bloom S A, Palmore M P. Human immunodeficiency virus-associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution. J Neurovirol. 2010; 16 (2) 179-184
- 123 Berkeley J L, Nath A, Pardo C A. Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: case report and review of the literature. J Neurovirol. 2008; 14 (3) 267-276
- 124 Broom J, Woods II M, Allworth A. Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningitis: case report and a review of immune reconstitution-associated cryptococcal infections. Scand J Infect Dis. 2006; 38 (3) 219-221
- 125 French M A, Lenzo N, John M et al.. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000; 1 (2) 107-115
- 126 Lawn S D. Immune reconstitution disease associated with parasitic infections following initiation of antiretroviral therapy. Curr Opin Infect Dis. 2007; 20 (5) 482-488
- 127 Lee C H, Lui C C, Liu J W. Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma. AIDS Patient Care STDS. 2007; 21 (4) 234-239
- 128 Lindzen E, Jewells V, Bouldin T, Speer D, Royal III W, Markovic-Plese S. Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. J Neurovirol. 2008; 14 (6) 569-573
- 129 Melica G, Brugieres P, Lascaux A S, Levy Y, Lelièvre J D. Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. J Med Virol. 2009; 81 (4) 578-581
- 130 Newsome S D, Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol. 2009; 15 (3) 288-291
- 131 Nolan R C, Chidlow G, French M A. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection. Clin Infect Dis. 2003; 36 (9) 1191-1194
- 132 Patel A K, Patel K K, Shah S D, Desai J. Immune reconstitution syndrome presenting with cerebral varicella zoster vasculitis in HIV-1-infected patient: a case report. J Int Assoc Physicians AIDS Care (Chic). 2006; 5 (4) 157-160
- 133 Pfeffer G, Prout A, Hooge J, Maguire J. Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis. Neurology. 2009; 73 (4) 321-322
- 134 Teo E C, Azwra A, Jones R L, Gazzard B G, Nelson M. Guillain-Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Ther. 2007; 12 (3) 62-63
- 135 Toro C, Blanco F, García-Gascó P et al.. Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy. Clin Infect Dis. 2007; 45 (9) e118-e120
- 136 Vidal J E, Fink M C, Cedeno-Laurent F et al.. BK virus associated meningoencephalitis in an AIDS patient treated with HAART. AIDS Res Ther. 2007; 4 13
- 137 York J, Bodi I, Reeves I, Riordan-Eva P, Easterbrook P J. Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?. J Infect. 2005; 51 (2) 165-171
Jennifer LyonsM.D.
Department of Neurology, Massachusetts General Hospital
45 Fruit Street, Wang 835, Boston, MA 02114
eMail: jlyons5@partners.org